SECsense Logo

Moleculin Biotech, Inc. 8-K Report: Key Updates on Corporate Developments

$MBRX
Form 8-K
Filed on: 2025-02-13
Source
Moleculin Biotech, Inc. 8-K Report: Key Updates on Corporate Developments

Based on the provided section of the financial report, here are the key extracted points:

  1. Entity Information:
  • Company Name: Moleculin Biotech, Inc.
  • State of Incorporation: Delaware (DE)
  • CIK Number: 0001659617
  • IRS Employer Identification Number: 47-4671997
  • Address: 5300 Memorial Drive, Suite 950, Houston, TX 77007
  • Phone Number: 713-300-5160
  1. Filing Information:
  • Filing Type: 8-K (Current Report)
  • Filing Date: February 13, 2025
  • Period Covered: February 13, 2025
  1. Securities Information:
  • Common Stock: Par value of $0.001 per share
  • Ticker Symbol: MBRX
  • Exchange: NASDAQ
  1. Context:
  • This filing is associated with a specific context id (d20258K), indicating it is a unique submission within the SEC's database.

Insights:

  • The company is publicly traded on NASDAQ under the ticker MBRX, which indicates it is likely subject to SEC regulations and is required to file timely disclosures.
  • The 8-K filing suggests that there may be significant events or developments that the company is required to report, which could impact its stock price or investor perception.
  • Being a biotech company, stakeholders may be particularly interested in any clinical trial results, regulatory approvals, or partnerships that could be reported in this filing.

This information is crucial for investors and analysts monitoring Moleculin Biotech, Inc. for any significant corporate developments or changes that may affect the company's future performance.